← Back to directory
AP
Alnylam Pharmaceuticals
🧬 Genetic Testing
Overview
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in RNA interference (RNAi) therapeutics for genetic and rare diseases. The company develops and commercializes innovative treatments informed by genetic testing and molecular diagnostics to address serious conditions with limited treatment options.
More in Genetic Testing
Company details
Category
🧬 Genetic Testing
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →